Ranbaxy, Inc.v.Adamas Pharmaceuticals, Inc.Download PDFPatent Trial and Appeal BoardMay 15, 201513536525 (P.T.A.B. May. 15, 2015) Copy Citation Trials@uspto.gov Paper No. 20 571.272.7822 Entered: May 15, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE ____________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ____________ RANBAXY LABORATORIES LTD. and RANBAXY INC., Petitioner, v. ADAMAS PHARMACEUTICALS, INC., Patent Owner. ____________ Case IPR2015-00410 Patent 8,362,085 B2 ____________ Before JACQUELINE WRIGHT BONILLA, ZHENYU YANG, and TINA E. HULSE, Administrative Patent Judges. HULSE, Administrative Patent Judge. DECISION Termination of the Proceeding 35 U.S.C. § 317(a) IPR2015-00410 Patent 8,362,085 B2 2 On May 13, 2015, and pursuant to 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74, the parties filed a copy of a settlement agreement (Ex. 2008) along with a joint request to treat the settlement agreement as business confidential, to be separate from the patent file (Paper 19). In addition, the parties filed a joint motion to terminate the case under 35 U.S.C. § 317(a). Paper 18. This case is in an early stage and no institution of a trial has been made. Based on the facts of this case, it is appropriate to terminate the case. Therefore, the joint motion to terminate the case is GRANTED. Accordingly, it is ORDERED that the parties’ request that the settlement agreement be treated as business confidential information, to be kept separate from the patent file, is GRANTED; FURTHER ORDERED that the joint motion to terminate the case is GRANTED; FURTHER ORDERED that the case is TERMINATED. IPR2015-00410 Patent 8,362,085 B2 3 PETITIONER: John W. Bateman Karen Shen KENYON & KENYON LLP jbateman@kenyon.com kshen@kenyon.com PATENT OWNER: Peter J. Armenio Evangeline Shih QUINN EMANUEL URQUHART & SULLIVAN, LLP peterarmenio@quinnemanuel.com evangelineshih@quinnemanuel.com Copy with citationCopy as parenthetical citation
